and see if the neurotoxicity is actually present in that model or not. This could have significant regulatory implications.
The resources that we have at our disposition are all the laboratories within OTR and those include the Laboratory of Clinical Pharmacology, the Laboratory of Pharmaceutical Analysis, which is located in St. Louis, the Division of Product Quality Research, and the Division of Applied Pharmacology and Research, and in addition to that, we also have contracts set up with several universities, including the University of Tennessee and the Uniformed Services University. The work that we did with the palatability studies, for example, was done by the University of Tennessee.
In fact, right now, we're working on another palatability study and that's the palatability of ciprofloxacin tablets in human subjects, again to identify appropriate dosing regimens for pediatric populations in the event of a bioterrorism incident. Again, this is because the national stockpile has only got solid oral dosage forms, and it's important just to know if we can actually prepare a solution from these solid oral dosage